Citigroup’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.6M | Buy |
2,527,031
+1,694,708
| +204% | +$56.4M | 0.03% | 526 |
|
|
2026
Q1 | $25.1M | Sell |
832,323
-511,168
| -38% | -$16.4M | 0.01% | 953 |
|
|
2025
Q4 | $41.9M | Buy |
1,343,491
+663,120
| +97% | +$16.3M | 0.02% | 701 |
|
|
2025
Q3 | $13.7M | Sell |
680,371
-432,251
| -39% | -$7.59M | 0.01% | 1283 |
|
|
2025
Q2 | $18.6M | Sell |
1,112,622
-2,956,644
| -73% | -$47.7M | 0.01% | 1006 |
|
|
2025
Q1 | $62.5M | Buy |
4,069,266
+3,752,000
| +1,183% | +$67M | 0.03% | 491 |
|
|
2024
Q4 | $6.99M | Buy |
317,266
+18,319
| +6% | +$333K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $5.39M | Sell |
298,947
-637,465
| -68% | -$11.2M | ﹤0.01% | 1781 |
|
|
2024
Q2 | $15.2M | Sell |
936,412
-2,681,335
| -74% | -$41.3M | 0.01% | 1029 |
|
|
2024
Q1 | $51M | Buy |
3,617,747
+3,247,067
| +876% | +$40.9M | 0.03% | 469 |
|
|
2023
Q4 | $3.87M | Sell |
370,680
-35,804
| -9% | -$334K | ﹤0.01% | 1764 |
|
|
2023
Q3 | $4.15M | Sell |
406,484
-328,347
| -45% | -$3.06M | ﹤0.01% | 1543 |
|
|
2023
Q2 | $5.53M | Sell |
734,831
-4,060,549
| -85% | -$32.9M | ﹤0.01% | 1436 |
|
|
2023
Q1 | $42.4M | Buy |
4,795,380
+4,043,784
| +538% | +$40M | 0.03% | 465 |
|
|
2022
Q4 | $6.85M | Sell |
751,596
-458,241
| -38% | -$4M | 0.01% | 1320 |
|
|
2022
Q3 | $9.76M | Sell |
1,209,837
-3,468,047
| -74% | -$30.7M | 0.01% | 1151 |
|
|
2022
Q2 | $35.2M | Buy |
4,677,884
+4,398
| +0.1% | +$38.3K | 0.03% | 527 |
|
|
2022
Q1 | $43.9M | Sell |
4,673,486
-1,032,819
| -18% | -$8.62M | 0.03% | 555 |
|
|
2021
Q4 | $45.7M | Buy |
5,706,305
+3,620,439
| +174% | +$32.7M | 0.02% | 596 |
|
|
2021
Q3 | $20.3M | Sell |
2,085,866
-1,866,840
| -47% | -$17.5M | 0.01% | 996 |
|
|
2021
Q2 | $39.1M | Buy |
3,952,706
+1,527,717
| +63% | +$16.2M | 0.02% | 635 |
|
|
2021
Q1 | $28M | Sell |
2,424,989
-688,300
| -22% | -$7.89M | 0.02% | 766 |
|
|
2020
Q4 | $30M | Sell |
3,113,289
-6,203
| -0.2% | -$59.4K | 0.02% | 796 |
|
|
2020
Q3 | $28.1M | Sell |
3,119,492
-96,690
| -3% | -$1.02M | 0.02% | 740 |
|
|
2020
Q2 | $39.7M | Buy |
3,216,182
+217,097
| +7% | +$2.46M | 0.03% | 477 |
|
|
2020
Q1 | $26.9M | Buy |
2,999,085
+103,238
| +4% | +$1.06M | 0.02% | 589 |
|
|
2019
Q4 | $28.4M | Buy |
2,895,847
+164,963
| +6% | +$1.47M | 0.02% | 778 |
|
|
2019
Q3 | $18.8M | Sell |
2,730,884
-714,437
| -21% | -$5.47M | 0.01% | 948 |
|
|
2019
Q2 | $31.8M | Sell |
3,445,321
-666,134
| -16% | -$8.03M | 0.03% | 658 |
|
|
2019
Q1 | $64.5M | Buy |
4,111,455
+2,071,417
| +102% | +$36.5M | 0.06% | 303 |
|
|
2018
Q4 | $31.5M | Sell |
2,040,038
-2,951,725
| -59% | -$60.5M | 0.03% | 594 |
|
|
2018
Q3 | $108M | Sell |
4,991,763
-576,844
| -10% | -$13.4M | 0.1% | 180 |
|
|
2018
Q2 | $135M | Buy |
5,568,607
+3,987,104
| +252% | +$81.3M | 0.12% | 127 |
|
|
2018
Q1 | $27M | Sell |
1,581,503
-547,112
| -26% | -$10.7M | 0.02% | 633 |
|
|
2017
Q4 | $40.3M | Buy |
2,128,615
+207,530
| +11% | +$3.12M | 0.03% | 503 |
|
|
2017
Q3 | $33.8M | Buy |
1,921,085
+736,602
| +62% | +$16.6M | 0.03% | 545 |
|
|
2017
Q2 | $39.4M | Sell |
1,184,483
-348,057
| -23% | -$10.8M | 0.04% | 446 |
|
|
2017
Q1 | $49.2M | Buy |
1,532,540
+661,269
| +76% | +$22.6M | 0.04% | 366 |
|
|
2016
Q4 | $31.6M | Sell |
871,271
-162,829
| -16% | -$6.5M | 0.03% | 546 |
|
|
2016
Q3 | $47.6M | Buy |
1,034,100
+848,209
| +456% | +$44.3M | 0.04% | 360 |
|
|
2016
Q2 | $9.34M | Sell |
185,891
-38,723
| -17% | -$2.06M | 0.01% | 1081 |
|
|
2016
Q1 | $12M | Sell |
224,614
-27,642
| -11% | -$1.62M | 0.01% | 877 |
|
|
2015
Q4 | $16.6M | Sell |
252,256
-133,581
| -35% | -$8.26M | 0.02% | 832 |
|
|
2015
Q3 | $21.8M | Buy |
385,837
+38,835
| +11% | +$2.52M | 0.02% | 680 |
|
|
2015
Q2 | $20.5M | Buy |
347,002
+89,312
| +35% | +$5.51M | 0.02% | 768 |
|
|
2015
Q1 | $16.1M | Sell |
257,690
-81,543
| -24% | -$4.74M | 0.02% | 898 |
|
|
2014
Q4 | $19.5M | Buy |
339,233
+25,463
| +8% | +$1.42M | 0.02% | 825 |
|
|
2014
Q3 | $16.9M | Sell |
313,770
-61,362
| -16% | -$3.25M | 0.01% | 912 |
|
|
2014
Q2 | $19.7M | Buy |
375,132
+87,321
| +30% | +$4.46M | 0.02% | 811 |
|
|
2014
Q1 | $15.2M | Sell |
287,811
-2,051,054
| -88% | -$94.8M | 0.02% | 887 |
|
|
2013
Q4 | $93.7M | Buy |
2,338,865
+1,679,676
| +255% | +$66.1M | 0.08% | 206 |
|
|
2013
Q3 | $24.9M | Buy |
659,189
+265,866
| +68% | +$10.4M | 0.02% | 626 |
|
|
2013
Q2 | $15.4M | Buy |
+393,323
| New | +$15.3M | 0.02% | 800 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Citigroup's TEVA Position: Q2 2026 in Review
Citigroup increased its Teva Pharmaceuticals (TEVA) stake by 204% in Q2 2026, buying an estimated $56.4M and bringing the position to 2,527,031 shares worth $85.6M. The position accounts for 0.03% of the portfolio, ranked #526.
Citigroup first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $135M in Q2 2018. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Citigroup held 2,527,031 shares of Teva Pharmaceuticals worth $85.6M as of Q2 2026.
- Citigroup bought 1,694,708 Teva Pharmaceuticals shares in Q2 2026, an estimated $56.4M.
- Teva Pharmaceuticals made up 0.03% of Citigroup's portfolio in Q2 2026, its #526 holding.
- Citigroup first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Teva Pharmaceuticals position peaked at $135M in Q2 2018.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.